Advertisement

Radiation Time, Dose, and Fractionation in the Treatment of Lung Cancer

  • Melenda D. Jeter
  • Ritsuko Komaki
  • James D. Cox
Part of the Medical Radiology Radiation Oncology book series (MEDRAD)

Keywords

Lung Cancer Small Cell Lung Cancer Radiat Oncol Biol Phys Radiation Therapy Oncology Group Concurrent Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ariyoshi Y, Fukuoka M, Furuse K et al (1994) Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Jpn J Clin Oncol 24:275–281PubMedGoogle Scholar
  2. Arriagada R, Le Chevalier T, Ruffie P et al (1990) Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group. Int J Radiat Oncol Biol Phys 19:1135–1138PubMedGoogle Scholar
  3. Arriagada R, Pellae-Cosset B, Cueto Ladron de Guevara JC et al (1991a) Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences. Radiotherapy and Oncology 20:91–98CrossRefPubMedGoogle Scholar
  4. Arriagada R, Le Chevalier T, Quiox E et al (1991b) ASTRO plenary: effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int J Radiat Oncol Biol Phys 20:1183–1190PubMedGoogle Scholar
  5. Arriagada R, Rutqvist LE, Mattsson A et al (1995) Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. Journal of Clinical Oncology 13:2869–2878PubMedGoogle Scholar
  6. Arriagada R, LeChevalier T, Rekacewicz C et al (1997) Cisplatin-based chemotherapy (CT) in patients with locally advanced non-small cell lung cancer (NSCLC): late analysis of a French randomized trial. Proc ASCO 16:446aGoogle Scholar
  7. Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patietns with small-cell lung cancer in complete remission. N Engl J Med 341:476–484CrossRefPubMedGoogle Scholar
  8. Auperin A, Le Pechoux C (2003) Meta-analysis of randomized trials evaluating cisplatin or carboplatin-based concomitant chemoradiation versus radiotherapy alone in locally advanced non-small cell lung cancer. 10th world conference on lung cancer, vol 41. Lung Cancer, Vancouver, Canada, p S69Google Scholar
  9. Belderbos JS, De Jaeger K, Heemsbergen WD et al (2003) First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66:119–126CrossRefPubMedGoogle Scholar
  10. Bradley JD, Graham MV, Winter KW et al (2003) Acute and late toxicity results of RTO G 9311: a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:S137–S138CrossRefGoogle Scholar
  11. Cancer Therapy Evaluation Program (1998) Common toxicity criteria, version 2.0: DCTD, NCI, NIH, DHHSGoogle Scholar
  12. Choi NC, Herndon JEI, Rosenman J et al (1998) Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 6:3528–3536Google Scholar
  13. Cox JD (1985) Large dose fractionation (hypofractionation). Cancer 55:2105–2111PubMedGoogle Scholar
  14. Cox JD, Gingerelli F, Ream NW et al (1972) Total pulmonary irradiation for metastases from testicular carcinoma. Radiology 105:163–167PubMedGoogle Scholar
  15. Diener-West M, Pajak TF, Bauer M et al (1991) Randomized dose searching phase ILE/II trials of fractionation in radiation therapy for cancer. J Natl Cancer Inst 83:1065–1071PubMedGoogle Scholar
  16. Emami B (1998) Optimization of volume in radiotherapy of non-small cell lung cancer: small volume. In: Mornex F, van Houtte P (eds) Treatment optimization for lung cancer: from classical to innovative procedures. Elsevier, Paris, pp 59–65Google Scholar
  17. Forster KM, Stevens CW, Kitamura K et al (2003) Changes of tumor motion patterns during a course of radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 57:S234CrossRefGoogle Scholar
  18. Fu KK, Pajak TF, Trotti A et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16PubMedGoogle Scholar
  19. Goto K, Nishiwaki Y, Takada M et al (1999) Final results of a phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (P) and etoposide (E) for limited-stage small cell lung cancer (LD-SCLC): the Japan Clinical Oncology Group (JCOG) study (abstract). Proc ASCO 18:A1805Google Scholar
  20. Graham MV, Purdy JA, Emami B et al (1995) Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 33:993–1000CrossRefPubMedGoogle Scholar
  21. Janaki L, Rector D, Turrisi A et al (1994) Patterns of failure and second malignancies from SWOG-8629: concurrent cisplatin, etoposide, vincristine, and once daily radiotherapy for the treatment of limited small cell lung cancer (abstract). Proc ASCO 13:331Google Scholar
  22. Komaki R, Scott C, Ettinger D et al (1997) Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 9204. Int J Radiat Oncol Biol Phys 38:149–155CrossRefPubMedGoogle Scholar
  23. Komaki R, Swann RS, Ettinger D (2003) Phase I study of thoracic radiation dose-escalation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC): Radiation Therapy Oncology Group (RTOG) Protocol 9712. Proc ASCO 22:631Google Scholar
  24. Lee JS, Scott CB, Komaki R et al (2002) Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52:362–370PubMedGoogle Scholar
  25. Liao Z, Komaki R, Stevens C (2002) Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 53:558–565CrossRefPubMedGoogle Scholar
  26. Liu HH, Wang X, Dong L et al Feasibility of sparing the lung and other thoracic structures with intensity-modulated radiation therapy (IMRT) for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys (in press)Google Scholar
  27. McCracken JD, Janaki LM, Crowley JJ (1990) Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group study. J Clin Oncol 8:892–898PubMedGoogle Scholar
  28. Moyers MF, Miller DW, Bush DA et al (2001) Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys 49:1429–1438CrossRefPubMedGoogle Scholar
  29. Murray N, Coy P, Pater JL et al (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clincial Trails Group. J Clin Oncol 11:336–344PubMedGoogle Scholar
  30. Perez CA, Stanley K, Rubin P et al (1988) A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-small cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 45:2744–2753Google Scholar
  31. Pignon JP, Arriagada R, Ihde DC et al (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618–1624PubMedGoogle Scholar
  32. Qiao X, Tullgren O, Ingmar L et al (2003) The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41:1–11CrossRefPubMedGoogle Scholar
  33. Saunders MI (2000) The implications of the CHART trial for the treatment of non-small cell lung cancer. Lung Cancer 2:177–178Google Scholar
  34. Saunders MI, Dische S, Barret S et al (1997) Continuous hyper-fractionated accelerated radiotherapy versus conventional radiotherapy in small-cell lung cancer: a randomized multicentre trial. Lancet 350:161–165CrossRefPubMedGoogle Scholar
  35. Sause WT, Scott C, Taylor S et al (1995) Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198–205PubMedGoogle Scholar
  36. Schaake-Koning C, van den Bogaert W, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326:524–530PubMedGoogle Scholar
  37. Seppenwoolde Y, Shirato H, Kitamura K et al (2002) Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys 53:822–834PubMedGoogle Scholar
  38. Shioyama Y, Tokuuye K, Okumura T et al (2003) Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56:7–13CrossRefPubMedGoogle Scholar
  39. Stevens CW, Munden RF, Forster KM et al (2002) Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. Int J Radiat Oncol Biol Phys 51:62–68Google Scholar
  40. Thames HD, Peters LJ, Withers HR et al (1983) Accelerated fractionation versus hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys 9:127–138PubMedGoogle Scholar
  41. Turrisi ATI, Kim K, Blum R et al (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265–271CrossRefPubMedGoogle Scholar
  42. Uematsu M, Shioda A, Suda A et al (2001) Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51:666–670CrossRefPubMedGoogle Scholar
  43. Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890–895PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Melenda D. Jeter
    • 1
  • Ritsuko Komaki
    • 1
  • James D. Cox
    • 1
  1. 1.Department of Radiation OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations